Company Info
Phone(801) 676-9695
Year Established
2013
Ticker
CLNN
Exchange
NASDAQ
Contacts
Rob EtheringtonPresident & CEO
Mark Mortenson
CSO
Morgan Brown
CFO
Michael Hotchkin
CDO
Jerry Miraglia, J.D.
General Counsel
Company Description
Clene is a clinical-stage biopharmaceutical company focused on the development of unique therapeutics for neurodegenerative diseases.